top of page
News, Events and Updates
Search
Anavex Completes Scale-Up Manufacturing of ANAVEX 2-73 for Phase I AD Clinical Trials
Sep 20, 2009
Anavex Reports Sigma Receptor Review Published in Leading Journal
Aug 26, 2009
ANAVEX Appoints Dr. Hervé de Kegrohen as CEO to Lead Company Through Clinical Trials & Future Growth
Jun 15, 2009
Pharmawire: Medivation, Anavex May Lower Oxidative Stress
Apr 7, 2009
Anavex Appoints Leading Alzheimer’s Disease Expert Dr. Mark Smith to Scientific Advisory Board
Feb 10, 2009
Anavex Scales Up Synthesis of ANAVEX 2-73 for Phase 1 Alzheimer’s Disease Study
Jan 30, 2009
Ground-Breaking Anti-Amnesic and Neuroprotective Effects of Alzheimer’s Compound ANAVEX 1-41
Dec 17, 2008
Anavex Presents Potent Neuroprotective Effects of ANAVEX 1-41 at Neuroscience 2008
Dec 4, 2008
Anavex Completes Successful Preclinical Studies on Lead Alzheimer’s Drug Candidate
Sep 1, 2008
48
49
50
51
52
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
